Published: Aug-2022|  Format: PDF | QY Research |  Number of pages: 113 | Code: MBI-1635636

Psychiatric Medications Market by Products (Antidepressants, Anti-anxiety Medications, Mood-stabilizing Medications, Antipsychotic Medications), by Applications (Hospital Use, Clinic Use, Household) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Select a Format




 Buy Now

The Global Psychiatric Medications Market was valued at USD XXX in 2022 and it is projected to surpass around USD XX by 2030 with a registered CAGR of xxx during the forecast period 2022 to 2030.

Growth factor

Our new latest report titled, global Psychiatric Medications Market comes up with comprehensive analysis of the industry including emerging trends and current development of the market. The report offers comprehensive insights of the industry with details of market share, size, revenue, growth opportunities, regional insights and major companies. The report provides all necessary and vital information related to the global market to help the buyer, the readers, investors get a complete understanding of the market and invest accordingly to the upcoming challenges and opportunities.

List of Key Players Operating in the Market:

The report provides in-depth research about each player operating in the global Psychiatric Medications Market along with its worldwide financial position, previous and upcoming business expansion plans, new product launches. The upcoming activities of the key players related to various strategies such as acquisitions, partnerships, mergers and, joint ventures, research and development investments.

  • Pfizer
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Johnson & Johnson
  • Novartis
  • H. Lundbeck
  • Abbott Laboratories
  • Otsuka Pharmaceutical
  • Gedeon Richter
  • Lupin Pharmaceuticals
  • Luye Pharma
  • SK Biopharmaceuticals

Market research report presents an analysis of all the data collected through primary and secondary resources. Our well experienced team of analyst collects all the information from several leading entities press release, government publication sources such as gold standard, silver standard, white papers, articles and websites, corporate filings including financial statements, annual reports, investor presentations, etc.

Our Report offers detailed insights market valuation, volume, share, outlook, production capacity and price analysis for the forecast period 2022-2030. Furthermore, the study also includes market segmentation on the basis of product, application, end-users, supply chain, distribution channel and other segment. Additionally, the study also includes market segmentation based on upstream downstream demand analysis, feedstock, and consumption rate and market share. It employs both primary and secondary methods of data collection to obtain relevant and sustainable information of the market.

This exclusive report includes detailed information about the market related activities such as Partnerships, stake holder position, Sole Traders, which create, develop, and conduct activities for the study and analysis of markets as per the customization and specifications of the client.

Segment Analysis of the Market:

The objective of the report mainly provides an essential overview of the Psychiatric Medications Market with detailed market segmentation by product, end-users, distribution channel, technology, content, type, application and region. The global market is expected to witness rapid growth during the forecast period. The report provides growth drivers, challenges, restraints of the region. It also offers the fastest growing segment with future scope, advancement emerging trends. The study examines the global scenario of the market by conducting an economy-wide assessment along with a comprehensive study involving product costs, drivers and restrictions, demands, profit analysis, production, distribution, and year-on-year growth rates.

By Type

  • Antidepressants
  • Anti-anxiety Medications
  • Mood-stabilizing Medications
  • Antipsychotic Medications

By Application

  • Hospital Use
  • Clinic Use
  • Household

Key Question Answered in this In-depth Market Report 2022-2028:

  • What was the market valued in the past year?
  • What will be the projected size, share and CAGR of the market?
  • What was the market status across the globe?
  • What are the profit margins in global Psychiatric Medications Market?
  • What are the growth factors boosts the market for the forecast period?
  • Which segment is going to boom in the near future?
  • What are the upcoming trends of the market?
  • Who are the key companies or players of the market?
  • Which is the fastest growing region of the global Psychiatric Medications Market?

Regional Insights:

The government initiative increasing the development activities of the Psychiatric Medications Market. On the other hand the major reason behind the growth is the market key players are expanding their operation in this region.

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Exclusive Report Offers:

  1. To study and analyze the global Psychiatric Medications Market consumption rate by key regions, type and application, historical data from past five years, and for upcoming years.
  2. The global research study look at the market to identify key influencing factors and entry barriers.
  3. To understand the structure of market by identifying and studying its various segments.
  4. To analyze with respect to individual prospects, growth factors, emerging trends, and their contribution to the whole market.
  5. Study focuses on the analysis of key players, to describe and analyze the sales volume, company size, share, value, market competition landscape, SWOT analysis and development plans in the near future.
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Psychiatric Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Antidepressants
        1.2.3 Anti-anxiety Medications
        1.2.4 Mood-stabilizing Medications
        1.2.5 Antipsychotic Medications
    1.3 Market by Application
        1.3.1 Global Psychiatric Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Use
        1.3.3 Clinic Use
        1.3.4 Household
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Psychiatric Medications Market Perspective (2017-2028)
    2.2 Psychiatric Medications Growth Trends by Region
        2.2.1 Psychiatric Medications Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Psychiatric Medications Historic Market Size by Region (2017-2022)
        2.2.3 Psychiatric Medications Forecasted Market Size by Region (2023-2028)
    2.3 Psychiatric Medications Market Dynamics
        2.3.1 Psychiatric Medications Industry Trends
        2.3.2 Psychiatric Medications Market Drivers
        2.3.3 Psychiatric Medications Market Challenges
        2.3.4 Psychiatric Medications Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Psychiatric Medications Players by Revenue
        3.1.1 Global Top Psychiatric Medications Players by Revenue (2017-2022)
        3.1.2 Global Psychiatric Medications Revenue Market Share by Players (2017-2022)
    3.2 Global Psychiatric Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Psychiatric Medications Revenue
    3.4 Global Psychiatric Medications Market Concentration Ratio
        3.4.1 Global Psychiatric Medications Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Psychiatric Medications Revenue in 2021
    3.5 Psychiatric Medications Key Players Head office and Area Served
    3.6 Key Players Psychiatric Medications Product Solution and Service
    3.7 Date of Enter into Psychiatric Medications Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Psychiatric Medications Breakdown Data by Type
    4.1 Global Psychiatric Medications Historic Market Size by Type (2017-2022)
    4.2 Global Psychiatric Medications Forecasted Market Size by Type (2023-2028)
5 Psychiatric Medications Breakdown Data by Application
    5.1 Global Psychiatric Medications Historic Market Size by Application (2017-2022)
    5.2 Global Psychiatric Medications Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Psychiatric Medications Market Size (2017-2028)
    6.2 North America Psychiatric Medications Market Size by Type
        6.2.1 North America Psychiatric Medications Market Size by Type (2017-2022)
        6.2.2 North America Psychiatric Medications Market Size by Type (2023-2028)
        6.2.3 North America Psychiatric Medications Market Share by Type (2017-2028)
    6.3 North America Psychiatric Medications Market Size by Application
        6.3.1 North America Psychiatric Medications Market Size by Application (2017-2022)
        6.3.2 North America Psychiatric Medications Market Size by Application (2023-2028)
        6.3.3 North America Psychiatric Medications Market Share by Application (2017-2028)
    6.4 North America Psychiatric Medications Market Size by Country
        6.4.1 North America Psychiatric Medications Market Size by Country (2017-2022)
        6.4.2 North America Psychiatric Medications Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Psychiatric Medications Market Size (2017-2028)
    7.2 Europe Psychiatric Medications Market Size by Type
        7.2.1 Europe Psychiatric Medications Market Size by Type (2017-2022)
        7.2.2 Europe Psychiatric Medications Market Size by Type (2023-2028)
        7.2.3 Europe Psychiatric Medications Market Share by Type (2017-2028)
    7.3 Europe Psychiatric Medications Market Size by Application
        7.3.1 Europe Psychiatric Medications Market Size by Application (2017-2022)
        7.3.2 Europe Psychiatric Medications Market Size by Application (2023-2028)
        7.3.3 Europe Psychiatric Medications Market Share by Application (2017-2028)
    7.4 Europe Psychiatric Medications Market Size by Country
        7.4.1 Europe Psychiatric Medications Market Size by Country (2017-2022)
        7.4.2 Europe Psychiatric Medications Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Psychiatric Medications Market Size (2017-2028)
    8.2 Asia-Pacific Psychiatric Medications Market Size by Type
        8.2.1 Asia-Pacific Psychiatric Medications Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Psychiatric Medications Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Psychiatric Medications Market Share by Type (2017-2028)
    8.3 Asia-Pacific Psychiatric Medications Market Size by Application
        8.3.1 Asia-Pacific Psychiatric Medications Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Psychiatric Medications Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Psychiatric Medications Market Share by Application (2017-2028)
    8.4 Asia-Pacific Psychiatric Medications Market Size by Region
        8.4.1 Asia-Pacific Psychiatric Medications Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Psychiatric Medications Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Psychiatric Medications Market Size (2017-2028)
    9.2 Latin America Psychiatric Medications Market Size by Type
        9.2.1 Latin America Psychiatric Medications Market Size by Type (2017-2022)
        9.2.2 Latin America Psychiatric Medications Market Size by Type (2023-2028)
        9.2.3 Latin America Psychiatric Medications Market Share by Type (2017-2028)
    9.3 Latin America Psychiatric Medications Market Size by Application
        9.3.1 Latin America Psychiatric Medications Market Size by Application (2017-2022)
        9.3.2 Latin America Psychiatric Medications Market Size by Application (2023-2028)
        9.3.3 Latin America Psychiatric Medications Market Share by Application (2017-2028)
    9.4 Latin America Psychiatric Medications Market Size by Country
        9.4.1 Latin America Psychiatric Medications Market Size by Country (2017-2022)
        9.4.2 Latin America Psychiatric Medications Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Psychiatric Medications Market Size (2017-2028)
    10.2 Middle East & Africa Psychiatric Medications Market Size by Type
        10.2.1 Middle East & Africa Psychiatric Medications Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Psychiatric Medications Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Psychiatric Medications Market Share by Type (2017-2028)
    10.3 Middle East & Africa Psychiatric Medications Market Size by Application
        10.3.1 Middle East & Africa Psychiatric Medications Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Psychiatric Medications Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Psychiatric Medications Market Share by Application (2017-2028)
    10.4 Middle East & Africa Psychiatric Medications Market Size by Country
        10.4.1 Middle East & Africa Psychiatric Medications Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Psychiatric Medications Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Psychiatric Medications Introduction
        11.1.4 Pfizer Revenue in Psychiatric Medications Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Details
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Psychiatric Medications Introduction
        11.2.4 AstraZeneca Revenue in Psychiatric Medications Business (2017-2022)
        11.2.5 AstraZeneca Recent Developments
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Company Details
        11.3.2 Eli Lilly and Company Business Overview
        11.3.3 Eli Lilly and Company Psychiatric Medications Introduction
        11.3.4 Eli Lilly and Company Revenue in Psychiatric Medications Business (2017-2022)
        11.3.5 Eli Lilly and Company Recent Developments
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Details
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Psychiatric Medications Introduction
        11.4.4 GlaxoSmithKline Revenue in Psychiatric Medications Business (2017-2022)
        11.4.5 GlaxoSmithKline Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Psychiatric Medications Introduction
        11.5.4 Johnson & Johnson Revenue in Psychiatric Medications Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Developments
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Psychiatric Medications Introduction
        11.6.4 Novartis Revenue in Psychiatric Medications Business (2017-2022)
        11.6.5 Novartis Recent Developments
    11.7 H. Lundbeck
        11.7.1 H. Lundbeck Company Details
        11.7.2 H. Lundbeck Business Overview
        11.7.3 H. Lundbeck Psychiatric Medications Introduction
        11.7.4 H. Lundbeck Revenue in Psychiatric Medications Business (2017-2022)
        11.7.5 H. Lundbeck Recent Developments
    11.8 Abbott Laboratories
        11.8.1 Abbott Laboratories Company Details
        11.8.2 Abbott Laboratories Business Overview
        11.8.3 Abbott Laboratories Psychiatric Medications Introduction
        11.8.4 Abbott Laboratories Revenue in Psychiatric Medications Business (2017-2022)
        11.8.5 Abbott Laboratories Recent Developments
    11.9 Otsuka Pharmaceutical
        11.9.1 Otsuka Pharmaceutical Company Details
        11.9.2 Otsuka Pharmaceutical Business Overview
        11.9.3 Otsuka Pharmaceutical Psychiatric Medications Introduction
        11.9.4 Otsuka Pharmaceutical Revenue in Psychiatric Medications Business (2017-2022)
        11.9.5 Otsuka Pharmaceutical Recent Developments
    11.10 Gedeon Richter
        11.10.1 Gedeon Richter Company Details
        11.10.2 Gedeon Richter Business Overview
        11.10.3 Gedeon Richter Psychiatric Medications Introduction
        11.10.4 Gedeon Richter Revenue in Psychiatric Medications Business (2017-2022)
        11.10.5 Gedeon Richter Recent Developments
    11.11 Lupin Pharmaceuticals
        11.11.1 Lupin Pharmaceuticals Company Details
        11.11.2 Lupin Pharmaceuticals Business Overview
        11.11.3 Lupin Pharmaceuticals Psychiatric Medications Introduction
        11.11.4 Lupin Pharmaceuticals Revenue in Psychiatric Medications Business (2017-2022)
        11.11.5 Lupin Pharmaceuticals Recent Developments
    11.12 Luye Pharma
        11.12.1 Luye Pharma Company Details
        11.12.2 Luye Pharma Business Overview
        11.12.3 Luye Pharma Psychiatric Medications Introduction
        11.12.4 Luye Pharma Revenue in Psychiatric Medications Business (2017-2022)
        11.12.5 Luye Pharma Recent Developments
    11.13 SK Biopharmaceuticals
        11.13.1 SK Biopharmaceuticals Company Details
        11.13.2 SK Biopharmaceuticals Business Overview
        11.13.3 SK Biopharmaceuticals Psychiatric Medications Introduction
        11.13.4 SK Biopharmaceuticals Revenue in Psychiatric Medications Business (2017-2022)
        11.13.5 SK Biopharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables Table 1. Global Psychiatric Medications Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Antidepressants Table 3. Key Players of Anti-anxiety Medications Table 4. Key Players of Mood-stabilizing Medications Table 5. Key Players of Antipsychotic Medications Table 6. Global Psychiatric Medications Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Psychiatric Medications Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Psychiatric Medications Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Psychiatric Medications Market Share by Region (2017-2022) Table 10. Global Psychiatric Medications Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Psychiatric Medications Market Share by Region (2023-2028) Table 12. Psychiatric Medications Market Trends Table 13. Psychiatric Medications Market Drivers Table 14. Psychiatric Medications Market Challenges Table 15. Psychiatric Medications Market Restraints Table 16. Global Psychiatric Medications Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Psychiatric Medications Revenue Share by Players (2017-2022) Table 18. Global Top Psychiatric Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychiatric Medications as of 2021) Table 19. Ranking of Global Top Psychiatric Medications Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Psychiatric Medications Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Psychiatric Medications Product Solution and Service Table 23. Date of Enter into Psychiatric Medications Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Psychiatric Medications Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Psychiatric Medications Revenue Market Share by Type (2017-2022) Table 27. Global Psychiatric Medications Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Psychiatric Medications Revenue Market Share by Type (2023-2028) Table 29. Global Psychiatric Medications Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Psychiatric Medications Revenue Share by Application (2017-2022) Table 31. Global Psychiatric Medications Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Psychiatric Medications Revenue Share by Application (2023-2028) Table 33. North America Psychiatric Medications Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Psychiatric Medications Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Psychiatric Medications Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Psychiatric Medications Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Psychiatric Medications Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Psychiatric Medications Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Psychiatric Medications Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Psychiatric Medications Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Psychiatric Medications Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Psychiatric Medications Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Psychiatric Medications Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Psychiatric Medications Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Psychiatric Medications Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Psychiatric Medications Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Psychiatric Medications Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Psychiatric Medications Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Psychiatric Medications Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Psychiatric Medications Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Psychiatric Medications Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Psychiatric Medications Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Psychiatric Medications Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Psychiatric Medications Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Psychiatric Medications Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Psychiatric Medications Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Psychiatric Medications Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Psychiatric Medications Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Psychiatric Medications Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Psychiatric Medications Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Psychiatric Medications Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Psychiatric Medications Market Size by Country (2023-2028) & (US$ Million) Table 63. Pfizer Company Details Table 64. Pfizer Business Overview Table 65. Pfizer Psychiatric Medications Product Table 66. Pfizer Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 67. Pfizer Recent Developments Table 68. AstraZeneca Company Details Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Psychiatric Medications Product Table 71. AstraZeneca Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 72. AstraZeneca Recent Developments Table 73. Eli Lilly and Company Company Details Table 74. Eli Lilly and Company Business Overview Table 75. Eli Lilly and Company Psychiatric Medications Product Table 76. Eli Lilly and Company Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 77. Eli Lilly and Company Recent Developments Table 78. GlaxoSmithKline Company Details Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Psychiatric Medications Product Table 81. GlaxoSmithKline Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 82. GlaxoSmithKline Recent Developments Table 83. Johnson & Johnson Company Details Table 84. Johnson & Johnson Business Overview Table 85. Johnson & Johnson Psychiatric Medications Product Table 86. Johnson & Johnson Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 87. Johnson & Johnson Recent Developments Table 88. Novartis Company Details Table 89. Novartis Business Overview Table 90. Novartis Psychiatric Medications Product Table 91. Novartis Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 92. Novartis Recent Developments Table 93. H. Lundbeck Company Details Table 94. H. Lundbeck Business Overview Table 95. H. Lundbeck Psychiatric Medications Product Table 96. H. Lundbeck Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 97. H. Lundbeck Recent Developments Table 98. Abbott Laboratories Company Details Table 99. Abbott Laboratories Business Overview Table 100. Abbott Laboratories Psychiatric Medications Product Table 101. Abbott Laboratories Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 102. Abbott Laboratories Recent Developments Table 103. Otsuka Pharmaceutical Company Details Table 104. Otsuka Pharmaceutical Business Overview Table 105. Otsuka Pharmaceutical Psychiatric Medications Product Table 106. Otsuka Pharmaceutical Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 107. Otsuka Pharmaceutical Recent Developments Table 108. Gedeon Richter Company Details Table 109. Gedeon Richter Business Overview Table 110. Gedeon Richter Psychiatric Medications Product Table 111. Gedeon Richter Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 112. Gedeon Richter Recent Developments Table 113. Lupin Pharmaceuticals Company Details Table 114. Lupin Pharmaceuticals Business Overview Table 115. Lupin Pharmaceuticals Psychiatric Medications Product Table 116. Lupin Pharmaceuticals Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 117. Lupin Pharmaceuticals Recent Developments Table 118. Luye Pharma Company Details Table 119. Luye Pharma Business Overview Table 120. Luye Pharma Psychiatric Medications Product Table 121. Luye Pharma Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 122. Luye Pharma Recent Developments Table 123. SK Biopharmaceuticals Company Details Table 124. SK Biopharmaceuticals Business Overview Table 125. SK Biopharmaceuticals Psychiatric Medications Product Table 126. SK Biopharmaceuticals Revenue in Psychiatric Medications Business (2017-2022) & (US$ Million) Table 127. SK Biopharmaceuticals Recent Developments Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Global Psychiatric Medications Market Share by Type: 2021 VS 2028 Figure 2. Antidepressants Features Figure 3. Anti-anxiety Medications Features Figure 4. Mood-stabilizing Medications Features Figure 5. Antipsychotic Medications Features Figure 6. Global Psychiatric Medications Market Share by Application: 2021 VS 2028 Figure 7. Hospital Use Case Studies Figure 8. Clinic Use Case Studies Figure 9. Household Case Studies Figure 10. Psychiatric Medications Report Years Considered Figure 11. Global Psychiatric Medications Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Psychiatric Medications Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Psychiatric Medications Market Share by Region: 2021 VS 2028 Figure 14. Global Psychiatric Medications Market Share by Players in 2021 Figure 15. Global Top Psychiatric Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychiatric Medications as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Psychiatric Medications Revenue in 2021 Figure 17. North America Psychiatric Medications Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Psychiatric Medications Market Size Market Share by Type (2017-2028) Figure 19. North America Psychiatric Medications Market Size Market Share by Application (2017-2028) Figure 20. North America Psychiatric Medications Market Size Share by Country (2017-2028) Figure 21. United States Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Psychiatric Medications Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Psychiatric Medications Market Size Market Share by Type (2017-2028) Figure 25. Europe Psychiatric Medications Market Size Market Share by Application (2017-2028) Figure 26. Europe Psychiatric Medications Market Size Share by Country (2017-2028) Figure 27. Germany Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Psychiatric Medications Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Psychiatric Medications Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Psychiatric Medications Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Psychiatric Medications Market Size Share by Region (2017-2028) Figure 37. China Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Psychiatric Medications Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Psychiatric Medications Market Size Market Share by Type (2017-2028) Figure 45. Latin America Psychiatric Medications Market Size Market Share by Application (2017-2028) Figure 46. Latin America Psychiatric Medications Market Size Share by Country (2017-2028) Figure 47. Mexico Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Psychiatric Medications Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Psychiatric Medications Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Psychiatric Medications Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Psychiatric Medications Market Size Share by Country (2017-2028) Figure 53. Turkey Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Psychiatric Medications Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Pfizer Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 57. AstraZeneca Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 58. Eli Lilly and Company Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 59. GlaxoSmithKline Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 60. Johnson & Johnson Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 61. Novartis Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 62. H. Lundbeck Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 63. Abbott Laboratories Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 64. Otsuka Pharmaceutical Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 65. Gedeon Richter Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 66. Lupin Pharmaceuticals Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 67. Luye Pharma Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 68. SK Biopharmaceuticals Revenue Growth Rate in Psychiatric Medications Business (2017-2022) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global UAV Propulsion System Market to Grow at a (CAGR) of 11.8% during the Forecast Period 2022-2030

26-Sep-2022 | Semiconductor

As specified in the market business insights exclusive report, the global UAV Propulsion System Market is projected to reach USD 34,258.31 million by 2030. Growth Drivers: Market dynamics are the forces that influence the prices and b ...

Global Autonomous Vehicle Simulation Solution Market to Grow at a (CAGR) of 12.8% during the Forecast Period 2022-2030

24-Sep-2022 | Automobile

As specified in our exclusive report, the global Autonomous Vehicle Simulation Solution Market is projected to reach USD 2,515 Million by 2030. Growth Drivers: Increasing adoption of connected ve ...

Global Active Space Debris Removal Market to Grow at a (CAGR) of 23.9% during the Forecast Period 2022-2030

23-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global  Active Space Debris Removal Market size is projected to reach USD 452.65 million by 2030. According to the European Space Agency (ESA), there have been more than 5,000 launches into space ...

Global Small Arms Market to Grow at a (CAGR) of 4.8% during the Forecast Period 2022-2030

22-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global Small Arms Market is projected to reach USD 12.88 billion by 2030. The defense sector is upgrading weapons and ammunition and adopting more modern weapon systems, and deployments at military bases, i ...

Global RFID in Healthcare Market to Grow at a (CAGR) of 21.5% during the Forecast Period 2022-2030

21-Sep-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global RFID in Healthcare Market is projected to reach USD 12.06 billion by 2030. How RFID is Use in Healthcare Market? RFID applications in healthcare have been positi ...

More News...